Table 3.

Cost per patient breakdown

Treatment schedules (first line)	Total mean inpatient cost/patient (including empiric) €a
	Total inpatient (pharmaceuticals and medical)	Pharmaceuticals	Hospitalization costs	AE management costs	First-line failure costs
LINE	2,457	568	1,889	58	90
VANCO	2,762	249	2,513	58	90
DAPTO	2,850	753	2,097	58	90
TEICO	3,094	300	2,796	58	90
TIGE	3,494	886	2,607	58	90

AE adverse events, DAPTO daptomycin, LINE linezolid, TEICO teicoplanin, TIGE tigecycline, VANCO vancomycin

^aTotal mean cost per “typical” patient includes medical costs and antibiotic acquisition cost. Medical costs breakdown into cost per day of hospitalization, treatment failure and adverse event costs